Sweeney Karen sold $212K of AGX

Sweeney Karen sold 300 shares of ARGAN INC (AGX) at $705.00 ($0.21M total) on 2026-06-17.

Original reporting
SEC EDGAR · Sweeney Karen
Published Jun 17, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 17, 2026, 8:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AGX
Neutral
high confidence
Mentioned
$AGX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AGXNeutralLow
01

Why it matters

The disclosure updates ownership/flow information for AGX but does not introduce new operational or financial catalysts.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a major repricing.

03

What to watch

The article notes no pre-arranged 10b5-1 plan, but it still lacks motivation, tax context, or whether other insiders are selling/buying concurrently.

Relevance 4/10Novelty 5/10Timing: Filed 2026-06-17 (transaction dated 2026-06-17)

Background

The article is an SEC Form 4 insider transaction disclosure for Argan Inc.

Company-level read

Ticker impact

$AGXNeutralHigh confidence
Context

Argan Inc director Sweeney Karen sold 300 shares on 2026-06-17 at $705/share, totaling $211,500, per SEC Form 4.

Expected impact

Likely limited near-term impact; any effect should be small and short-lived unless follow-on selling appears.

Evidence & confidence

The filing is an insider sale without a 10b5-1 plan and provides exact size/price, but it does not disclose new company fundamentals or guidance.

Market effects

No sector-level read-through; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Director sales can be pre-planned for liquidity or diversification; without additional context, the sale may not reflect bearish expectations.

Key entities

  • Argan Inc

    Subject of the SEC Form 4 insider sale by a director.

  • Sweeney Karen

    Director who sold 300 shares at $705/share on 2026-06-17.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AGXMed

Silver X Files NI 43-101 Technical Report for the Updated Nueva Recuperada Mineral Resource: 10.4 Mt Measured and Indicated at 202 g/t AgEq (67.3 Moz AgEq) and 21.6 Mt Inferred at 260 g/t AgEq (184.3 Moz AgEq)

Silver X Mining Corp. (AGX) filed an updated NI 43-101 technical report for its Nueva Recuperada project in Peru, showing increased mineral resources. Measured and Indicated resources total 10.4 Mt with 67.3 Moz AgEq, up 107% from the previous estimate. Inferred resources total 21.6 Mt with 184.3 Moz AgEq. The report includes revisions from the September 22, 2026 news release, with no change in tonnage or classification. The company plans to expand its mining operations and plant capacity.

$AGXMedAI 8/10

Argan’s (AGX) Power Boom Comes With A Margin Catch

Argan (AGX) reported record Q2 revenue of $384.0M (+61.5% YoY) and net income of $53.3M, driven by its Power segment. Gross margin slipped to 19.3%, and backlog decreased to $2.5B. The company is debt-free with $1.03B in cash, returning $51.7M to shareholders. Management expects new projects but faces regulatory challenges and margin compression.

$AGXMed

Argan (AGX) Q2 2027 Earnings Call Transcript

Argan (AGX) reported Q2 2027 revenue of $384.0M, up 61.5%, with net income of $53.3M ($3.76 per diluted share). Power segment revenue grew 53% YoY to $301M, while Industrial segment revenue rose 111% to $76M. Consolidated backlog decreased to $2.5B. The company plans to complete a new fabrication facility in North Carolina by Q3 2027.